MLICM
AXGN icon

Metropolitan Life Insurance Company (MetLife)’s Axogen AXGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,211
Closed -$17.8K – 229
2024
Q1 		$17.8K Sell
2,211
-816
-27% -$7.31K ﹤0.01% 1920
2023
Q4 		$20.7K Hold
3,027
– – ﹤0.01% 1909
2023
Q3 		$15.1K Buy
3,027
+1,061
+54% +$7.35K ﹤0.01% 2024
2023
Q2 		$17.9K Hold
1,966
– – ﹤0.01% 1992
2023
Q1 		$18.6K Sell
1,966
-743
-27% -$6.8K ﹤0.01% 1919
2022
Q4 		$27K Hold
2,709
– – ﹤0.01% 1844
2022
Q3 		$32.3K Hold
2,709
– – ﹤0.01% 1751
2022
Q2 		$22.2K Hold
2,709
– – ﹤0.01% 1999
2022
Q1 		$21.5K Sell
2,709
-8,224
-75% -$71K ﹤0.01% 2055
2021
Q4 		$102K Sell
10,933
-312
-3% -$3.74K ﹤0.01% 2464
2021
Q3 		$178K Hold
11,245
– – ﹤0.01% 2169
2021
Q2 		$243K Buy
11,245
+1,094
+11% +$22.1K ﹤0.01% 2008
2021
Q1 		$206K Sell
10,151
-778
-7% -$15.4K ﹤0.01% 2003
2020
Q4 		$196K Hold
10,929
– – ﹤0.01% 1953
2020
Q3 		$127K Hold
10,929
– – ﹤0.01% 2081
2020
Q2 		$101K Hold
10,929
– – ﹤0.01% 2251
2020
Q1 		$114K Hold
10,929
– – ﹤0.01% 1952
2019
Q4 		$196K Hold
10,929
– – ﹤0.01% 1949
2019
Q3 		$136K Hold
10,929
– – ﹤0.01% 2130
2019
Q2 		$216K Hold
10,929
– – ﹤0.01% 1849
2019
Q1 		$230K Hold
10,929
– – ﹤0.01% 1808
2018
Q4 		$223K Hold
10,929
– – ﹤0.01% 1740
2018
Q3 		$403K Hold
10,929
– – 0.01% 1520
2018
Q2 		$549K Buy
10,929
+1,579
+17% +$69.6K 0.01% 1256
2018
Q1 		$341K Hold
9,350
– – ﹤0.01% 1524
2017
Q4 		$265K Sell
9,350
-10,553
-53% -$249K ﹤0.01% 1728
2017
Q3 		$385K Hold
19,903
– – ﹤0.01% 1859
2017
Q2 		$333K Hold
19,903
– – ﹤0.01% 1990
2017
Q1 		$208K Hold
19,903
– – ﹤0.01% 2243
2016
Q4 		$179K Buy
19,903
+2,935
+17% +$25.3K ﹤0.01% 2412
2016
Q3 		$153K Buy
+16,968
New +$138K ﹤0.01% 2484

Other funds holding AXGN

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AXGN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Axogen (AXGN) in Q2 2024, closing a stake of 2,211 shares — an estimated $17.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AXGN in Q3 2016 and held it in 31 quarters. The position peaked at $549K in Q2 2018. 125 funds tracked by Wall St. Rank hold AXGN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Axogen position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,211 Axogen shares in Q2 2024, an estimated $17.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Axogen in Q3 2016 and held it in 31 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Axogen position peaked at $549K in Q2 2018.
  • 125 funds tracked by Wall St. Rank held Axogen as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.